Probiotic lactic acid bacterium to treat bacterial infections associated with sids
CA 2292536 A1 · Owner: Ganeden Biotech, Inc. · Inventors: Mikhail, Robert J.; Farmer, Sean
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions including a non-pathogenic lactic acid-producing bacteria such , as a Bacillus species, spores or an extracellular product of B. coagulans formulated for oral administration to the intestinal tract for inhibiting bacterial gastrointestinal infections are described. Methods and systems using the compositions for treating gastrointestinal infections particularly sudden , infant death syndrome (SIDS) are also disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 3, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 3, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 3, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.